And dont forget wbt chair Dr Shanny Dyer if you believe in having good people on board nxr certainly is dealing with quality people in their quest to deliver their product to market.
Column 1
0
Dr. Shanny Dyer (BSc, GAICD, PhD (Biochem))
Column 1
0
Dr. Dyer previously was a General Manager of Planning, Performance and Evaluation at CSIRO. Dr. Dyer has more than 20 years experience in the Biotechnology industry sector and is a past Director of the National Organisation for AusBiotech Ltd as well as Chair and Founder of BIOCOM. Previously, Dr. Dyer was Entrepreneur in Residence at The University of Sydney where she assisted in startup ventures for medical devices. Dr. Dyer has also been an Investment Manager at Vericap Finance, General Manager / Scientific Director of AVAX Australia Pty Ltd (a company involved in the development and marketing of cancer vaccines), a member of the Executive group for the Medical Device Network and the National Health & Medical Research Council (NHMRC) Development Grant Panel.
NXR Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held
